Cellectis S.A. current report, Q2 FY2019

Cellectis S.A. Form 6-K Summary

Business Context and Reporting Period

This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, on April 17, 2019. The filing serves as a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934. The document primarily acts as a cover sheet for the submission of a press release dated April 17, 2019, as Exhibit 99.1.

Key Financial Metrics

The provided filing text does not contain specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity within this document. The filing text does not provide a clear value for any financial metric.

Material Changes

No material changes versus a prior comparable period are detailed in the text of this filing. The document does not include comparative financial statements or operational updates.

Guidance, Outlook, and Risks

The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are presumably contained within the referenced press release (Exhibit 99.1), which is not included in the input text.

Investor Verification Checklist

  • Verify the content of the press release dated April 17, 2019 (Exhibit 99.1), as the Form 6-K itself contains no substantive operational or financial data.
  • Confirm the specific announcement made by the company on this date, as the filing only references the existence of the release.
  • Review subsequent filings (e.g., Form 20-F) for detailed financial statements and risk factors.